Walleye Trading LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 140 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$517,236
+267.5%
73,056
+265.5%
0.00%
Q2 2023$140,730
-38.4%
19,990
-27.0%
0.00%
Q1 2023$228,516
-92.4%
27,400
-89.6%
0.00%
-100.0%
Q4 2022$3,014,705
+66.8%
262,605
+83.1%
0.01%
+60.0%
Q3 2022$1,807,000
+678.9%
143,389
+554.1%
0.01%
Q2 2022$232,000
-65.9%
21,920
-47.7%
0.00%
-100.0%
Q1 2022$681,000
-83.1%
41,932
-85.5%
0.00%
-84.6%
Q4 2021$4,019,000
-57.9%
290,122
-56.4%
0.01%
-60.6%
Q3 2021$9,553,000
+4.2%
664,803
+14.6%
0.03%
-8.3%
Q2 2021$9,171,000
+4049.8%
580,097
+1861.6%
0.04%
+3500.0%
Q4 2020$221,000
+163.1%
29,572
-29.7%
0.00%0.0%
Q1 2020$84,000
-46.2%
42,086
-6.7%
0.00%0.0%
Q4 2019$156,000
+1633.3%
45,086
+3521.4%
0.00%
Q3 2018$9,000
-97.2%
1,245
-96.7%
0.00%
-100.0%
Q1 2017$317,000
+1409.5%
37,700
+1785.0%
0.00%
Q4 2015$21,000
-48.8%
2,000
-44.4%
0.00%
Q3 2015$41,000
+485.7%
3,600
+620.0%
0.00%
Q2 2015$7,0005000.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
VHCP Management, LLC 1,744,356$18,455,0009.59%
RA Capital Management 4,347,456$45,996,0003.30%
Cormorant Asset Management, LP 1,168,000$12,357,0002.84%
Baker Brothers Advisors 5,867,031$62,073,0000.79%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 907,920$9,606,0000.39%
QVT Financial LP 525,734$5,562,0000.32%
EAM Investors, LLC 114,548$1,212,0000.22%
FRANKLIN STREET ADVISORS INC /NC 93,000$984,0000.20%
THB ASSET MANAGEMENT 301,529$3,190,0000.19%
TPG Group Holdings (SBS) Advisors, Inc. 1,162,269$12,297,0000.13%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders